hu1124: XOMA filed an IND for safety testing in 30 to 40 patients with moderate to severe psoriasis.

Xoma Corp. (XOMA), Berkeley, Calif. Product: hu1124 (anti-CD11a) humanized monoclonal antibody targeted to T cells Indication: Psoriasis Status: XOMA filed an IND for safety testing in 30 to 40 patien...